The History Of Genetic Engineering Is Being Written Now

History of genetic engineering is inevitably brief and without a great amount of incident, as this is a young technology with most of its potential still unrealized, and most of its effects still to come. There are significant lessons which can be learned from what has already happened, but much more research will need to be done before we can be certain of the exact potential of this technology, or of the inevitable challenges which will need to be overcome if this potential is to be realized. Even with this advanced technology, progress will come slowly.

Most of the history which is available so far relates to the use of genetic engineering in crop growing. This is the only part of the science which is currently in regular practice and regular commercial use, and which is established to a degree. The first generation of crop engineering involves producing strains which are more resistant to pesticides and other chemicals which are routinely used in the production of standard crops. This has already successfully been achieved, although the effect of the technology on the surrounding nature and the ecology of the planet remains to be seen.

The next generation of crop related genetic engineering is still being implemented, and this is the part which relates to making crops which are more resistant to extreme weather conditions. This would be extremely valuable technology in temperate climates where temperatures can vary from ten degrees or even more from the expected average for the time of year. There is always risk that crops will be destroyed when these extreme temperatures threaten, although the risk is less than in the past when technology was more primitive. History suggests that any application of a technology which is financially viable will eventually happen.

types of genetic engineering

There is already established history of genetic engineering in the area of manipulating human genes. So far, there has been considerable success in the treatment of immune system disorders using a technique of gene substitution. This relatively simple use of genetic engineering technology has so far permanently cured over ten people, and it is still in the early stages of development. The only downside has been that several other people have contracted leukemia as a result of attempting to use this technology. These incidents are believed to be due to incorrect implementation, rather than any inherent problem with the technology.

So many other applications of this technology have virtually no history beyond the laboratories in which they are developed. These include the ones which are still in an early stage, and the ones for which there is uncertainty as to whether or not they will ever be viable. A case in point is the relatively simple technology which can produce farm animals which are larger and more well developed than the naturally occurring animals. The same effect can be achieved with hormones, so it is not known whether or not there will ever be enough commercial demand for a genetically produced line of farm animals.

genetic engineering

The history of genetic engineering is still being written, and will continue to be written for a long time to come. There is certain to be much debate still going on many years from now, as new possible uses for the technology are developed. There are many highly vocal proponents of genetic engineering, and many equally loud and noticeable opponents, so much of the future history will be created in the government buildings of the world. As long as commercial interests have control over political activities, there are likely to be further developments in the history of genetic engineering.

 

 

 

Genetic Engineering News:

 

Human Neural Stem Cell Therapy for Chronic Ischemic Stroke | GEN - Genetic Engineering & Biotechnology News

Genetic Engineering & Biotechnology News

Human Neural Stem Cell Therapy for Chronic Ischemic Stroke | GEN
Genetic Engineering & Biotechnology News
Chronic disability after stroke represents a major unmet neurologic need. ReNeuron's development of a human neural stem cell (hNSC) therapy for chronic .

and more »
..

A Potent Tool to Treat Pancreatic Cancer May Already Be in Your Body - MIT Technology Review

MIT Technology Review

A Potent Tool to Treat Pancreatic Cancer May Already Be in Your Body
MIT Technology Review
Valerie LeBleu, assistant professor of cancer biology at the University of Texas MD Anderson Cancer Center, is working on genetically engineering exosomes to carry molecules that seek out pancreatic tumor cells to keep the cancer at bay. Her team .

..


FDA Panel Recommends Approval for Gene-Altering Leukemia Treatment - New York Times

New York Times

FDA Panel Recommends Approval for Gene-Altering Leukemia Treatment
New York Times
The treatment requires removing millions of a patient's T-cells EUR” a type of white blood cell often called soldiers of the immune system EUR” and genetically engineering them to kill cancer cells. The technique employs a disabled form of H.I.V., the .
BLA 125646 Tisagenlecleucel 1 FDA Briefing Document Oncologic Drugs Advisory Committee Meeting BLA 125646 .FDA
Childhood Acute Lymphoblastic Leukemia Treatment (PDQ)EUR”Patient Version - National Cancer InstituteNational Cancer Institute
FDA Panel OKs What May Soon Be First Gene Therapy Approved in USHealthDay

all 245 news articles »
..


Gene therapy to kill cancer moves a step closer to market - CNET - CNET

CNET

Gene therapy to kill cancer moves a step closer to market - CNET
CNET
An advisory panel says it's time patients had access to gene-altering treatments. If approved, the first to make it to market would take on a stubborn form of .

and more »
..


Background on biotechnology Bill - New Vision

New Vision

Background on biotechnology Bill
New Vision
Building on these sexual reproduction approaches to develop new crop types, the study of genetics later showed us that when you crossed plants of the same species from two lines of a crop that have distinct and stable attributes, their off-springs were .

..


 

share